Abstract
Nicotine addiction is the most common serious medical problem in the country. Tobacco use is responsible for 30% of cancer deaths in the United States and 90% of all lung cancer deaths. The physical addiction to nicotine explains why over 30% of Americans continue to smoke or use tobacco despite their desires and efforts to quit. The testimony summarized in this paper recommends four broad strategies for preventing tobacco-caused cancers in the United States: a) mandating and reimbursing effective treatments for nicotine addiction; b) increasing Federal and state tobacco excise taxes and earmarking a fraction of tax revenues for tobacco prevention and cessation; c) enacting other policy changes to prevent tobacco use and addiction among children, including expanded clean indoor air legislation, comprehensive youth tobacco access legislation, and the regulation of tobacco products and their advertising and promotion; and d) expanding tobacco control research and critical Federal research support. Specific recommendations are given for each broad strategy.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Fiore M. C., Novotny T. E., Pierce J. P., Giovino G. A., Hatziandreu E. J., Newcomb P. A., Surawicz T. S., Davis R. M. Methods used to quit smoking in the United States. Do cessation programs help? JAMA. 1990 May 23;263(20):2760–2765. [PubMed] [Google Scholar]
- Gritz E. R., Moon T. E. The new cancer prevention and control. Cancer Epidemiol Biomarkers Prev. 1992 Mar-Apr;1(3):163–165. [PubMed] [Google Scholar]
- Hadorn D. C. Setting health care priorities in Oregon. Cost-effectiveness meets the rule of rescue. JAMA. 1991 May 1;265(17):2218–2225. [PubMed] [Google Scholar]
- Kottke T. E., Battista R. N., DeFriese G. H., Brekke M. L. Attributes of successful smoking cessation interventions in medical practice. A meta-analysis of 39 controlled trials. JAMA. 1988 May 20;259(19):2883–2889. doi: 10.1001/jama.259.19.2883. [DOI] [PubMed] [Google Scholar]
- Krumholz H. M., Cohen B. J., Tsevat J., Pasternak R. C., Weinstein M. C. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol. 1993 Nov 15;22(6):1697–1702. doi: 10.1016/0735-1097(93)90598-u. [DOI] [PubMed] [Google Scholar]
- Lerman C., Orleans C. T., Engstrom P. F. Biological markers in smoking cessation treatment. Semin Oncol. 1993 Aug;20(4):359–367. [PubMed] [Google Scholar]
- Orleans C. T., Resch N., Noll E., Keintz M. K., Rimer B. K., Brown T. V., Snedden T. M. Use of transdermal nicotine in a state-level prescription plan for the elderly. A first look at 'real-world' patch users. JAMA. 1994 Feb 23;271(8):601–607. [PubMed] [Google Scholar]
- Oster G., Huse D. M., Delea T. E., Colditz G. A. Cost-effectiveness of nicotine gum as an adjunct to physician's advice against cigarette smoking. JAMA. 1986 Sep 12;256(10):1315–1318. [PubMed] [Google Scholar]